Braverman ER - Search Results

1

Coupling Genetic Addiction Risk Score (GARS) with Electrotherapy: Fighting Iatrogenic Opioid Dependence.

Blum K, Oscar-Berman M, Dinubile N, Giordano J, Braverman ER, Truesdell CE, Barh D, Badgaiyan R. Blum K, et al. Among authors: braverman er. J Addict Res Ther. 2013 Oct 31;4(163):1000163. doi: 10.4172/2155-6105.1000163. J Addict Res Ther. 2013. PMID: 24616834 Free PMC article.

2

The D2 dopamine receptor gene as a predictor of compulsive disease: Bayes' theorem.

Blum K, Wood RC, Braverman ER, Chen TJ, Sheridan PJ. Blum K, et al. Among authors: braverman er. Funct Neurol. 1995 Jan-Feb;10(1):37-44. Funct Neurol. 1995. PMID: 7649500 Review.

3

Prolonged P300 latency in a neuropsychiatric population with the D2 dopamine receptor A1 allele.

Blum K, Braverman ER, Dinardo MJ, Wood RC, Sheridan PJ. Blum K, et al. Among authors: braverman er. Pharmacogenetics. 1994 Dec;4(6):313-22. doi: 10.1097/00008571-199412000-00004. Pharmacogenetics. 1994. PMID: 7704037

4

Dopamine D2 receptor gene polymorphisms in Scandinavian chronic alcoholics: a reappraisal.

Blum K, Sheridan PJ, Wood R, Braverman ER. Blum K, et al. Among authors: braverman er. Eur Arch Psychiatry Clin Neurosci. 1995;245(1):50-2. doi: 10.1007/BF02191544. Eur Arch Psychiatry Clin Neurosci. 1995. PMID: 7786911 No abstract available.

5

Substance use disorder exacerbates brain electrophysiological abnormalities in a psychiatrically-ill population.

Braverman ER, Blum K. Braverman ER, et al. Clin Electroencephalogr. 1996;27(4 Suppl):5-27. doi: 10.1177/1550059496027s0402. Clin Electroencephalogr. 1996. PMID: 8902324

6

P300 (latency) event-related potential: an accurate predictor of memory impairment.

Braverman ER, Blum K. Braverman ER, et al. Clin Electroencephalogr. 2003 Jul;34(3):124-39. doi: 10.1177/155005940303400306. Clin Electroencephalogr. 2003. PMID: 14521274 Clinical Trial.

7

Delayed P300 latency correlates with abnormal Test of Variables of Attention (TOVA) in adults and predicts early cognitive decline in a clinical setting.

Braverman ER, Chen TJ, Schoolfield J, Martinez-Pons M, Arcuri V, Varshavskiy M, Gordon CA, Mengucci J, Blum SH, Meshkin B, Downs BW, Blum K. Braverman ER, et al. Adv Ther. 2006 Jul-Aug;23(4):582-600. doi: 10.1007/BF02850047. Adv Ther. 2006. PMID: 17050501

8

Reward deficiency syndrome in obesity: a preliminary cross-sectional trial with a Genotrim variant.

Blum K, Chen TJ, Meshkin B, Downs BW, Gordon CA, Blum S, Mengucci JF, Braverman ER, Arcuri V, Varshavskiy M, Deutsch R, Martinez-Pons M. Blum K, et al. Among authors: braverman er. Adv Ther. 2006 Nov-Dec;23(6):1040-51. doi: 10.1007/BF02850224. Adv Ther. 2006. PMID: 17276971 Clinical Trial.

9

The H-Wave device is an effective and safe non-pharmacological analgesic for chronic pain: a meta-analysis.

Blum K, Chen AL, Chen TJ, Prihoda TJ, Schoolfield J, DiNubile N, Waite RL, Arcuri V, Kerner M, Braverman ER, Rhoades P, Tung H. Blum K, et al. Among authors: braverman er. Adv Ther. 2008 Jul;25(7):644-57. doi: 10.1007/s12325-008-0073-3. Adv Ther. 2008. PMID: 18636234

10

Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary.

Blum K, Chen AL, Chen TJ, Braverman ER, Reinking J, Blum SH, Cassel K, Downs BW, Waite RL, Williams L, Prihoda TJ, Kerner MM, Palomo T, Comings DE, Tung H, Rhoades P, Oscar-Berman M. Blum K, et al. Among authors: braverman er. Theor Biol Med Model. 2008 Nov 12;5:24. doi: 10.1186/1742-4682-5-24. Theor Biol Med Model. 2008. PMID: 19014506 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters